Iovance Biotherapeutics (NASDAQ:IOVA): Q3 GAAP EPS of -$0.40 misses by $0.01.
Cash, cash equivalents, and short-term investments of $361.87M
Monday, November 4, 2019
Allscripts Healthcare Solutions EPS in-line, misses on revenue
Allscripts Healthcare Solutions (NASDAQ:MDRX): Q3 Non-GAAP EPS of $0.17 in-line; GAAP EPS of -$0.03 misses by $0.06.
Revenue of $444.6M (+1.1% Y/Y) misses by $5.44M.
Addus HomeCare EPS beats by $0.05, beats on revenue
Addus HomeCare (NASDAQ:ADUS): Q3 Non-GAAP EPS of $0.62 beats by $0.05; GAAP EPS of $0.38 misses by $0.13.
Revenue of $169.8M (+23.3% Y/Y) beats by $9.55M.
Deciphera Pharmaceuticals EPS misses by $0.12
Deciphera Pharmaceuticals (NASDAQ:DCPH): Q3 GAAP EPS of -$1.28 misses by $0.12.
Cash, cash equivalents and marketable securities of $635M.
Myriad Genetics EPS misses by $0.23, misses on revenue
Myriad Genetics (NASDAQ:MYGN): Q1 Non-GAAP EPS of $0.08 misses by $0.23; GAAP EPS of -$0.28 misses by $0.29.
Revenue of $186.3M (-7.9% Y/Y) misses by $16.04M.
Shares -18.52%.
Turning Point Therapeutics EPS misses by $0.07
Turning Point Therapeutics (NASDAQ:TPTX): Q3 GAAP EPS of -$0.63 misses by $0.07.
Cash, cash equivalents and marketable securities of $423.6M.
Tandem Diabetes Care EPS beats by $0.09, beats on revenue
Tandem Diabetes Care (NASDAQ:TNDM): Q3 GAAP EPS of -$0.09 beats by $0.09.
Revenue of $94.66M (+104.6% Y/Y) beats by $5.38M.
Shares -16.9%.
Subscribe to:
Comments (Atom)